JPMorgan Chase & Co’s Maze Therapeutics, Inc. Common Stock MAZE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$53.6K Sell
4,366
-5,775
-57% -$70.9K ﹤0.01% 5076
2025
Q1
$112K Buy
+10,141
New +$112K ﹤0.01% 4684